Page last updated: 2024-09-02

tadalafil and acetylleucyl-leucyl-norleucinal

tadalafil has been researched along with acetylleucyl-leucyl-norleucinal in 1 studies

Compound Research Comparison

Studies
(tadalafil)
Trials
(tadalafil)
Recent Studies (post-2010)
(tadalafil)
Studies
(acetylleucyl-leucyl-norleucinal)
Trials
(acetylleucyl-leucyl-norleucinal)
Recent Studies (post-2010) (acetylleucyl-leucyl-norleucinal)
1,7423921,089321053

Protein Interaction Comparison

ProteinTaxonomytadalafil (IC50)acetylleucyl-leucyl-norleucinal (IC50)
Calpain small subunit 1Homo sapiens (human)7
Calpain-1 catalytic subunitHomo sapiens (human)7
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus8.6
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 28.5967

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H1

Other Studies

1 other study(ies) available for tadalafil and acetylleucyl-leucyl-norleucinal

ArticleYear
Identifying off-target effects and hidden phenotypes of drugs in human cells.
    Nature chemical biology, 2006, Volume: 2, Issue:6

    Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006